In particular, CD80 with its later increase seems to be a useful indicator of CCH tumor cell maturation in this scenario, whereas the consistently high expression of CD86 may be interpreted as an indicator of an onset of tumor cell maturation earlier than the clinically apparent stage 1. Here, CD80 is linked to columnar cell hyperplasia of the breast.